Wenkang Yang

发表

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients

Zhengtian Li, G. Du, Rong Zhao, 2021, Medicine.

Identi cation And Validation Of A Hypoxia ‐ Related Prognostic Signature In Clear Cell Renal Cell Carcinoma Patients

Zhengtian Li, Rong Zhao, Wenkang Yang, 2020 .

Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes

Zhengtian Li, Wenkang Yang, Xi Li, 2022, Scientific Reports.

MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method

Zhengtian Li, Rong Zhao, Wenkang Yang, 2021, Medicine.

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma

Zhengtian Li, G. Du, Rong Zhao, 2021, Medicine.

Abstract. Vascular invasion (VI) is an important feature for systemic recurrence and an indicator for the application of adjuvant therapy in colorectal cancer (CRC). Preoperative knowledge of VI is important in determining whether adju‐

Weizhong Tang, L. Zhengtian, Wenkang Yang, 2019 .

Immunological role and prognostic value of the SKA family in pan-cancer analysis

Hong Wang, Zhengtian Li, Wenkang Yang, 2023, Frontiers in Immunology.

Nomogram for predicting overall survival in stage II‐III colorectal cancer

Weizhong Tang, Ling-xu Huang, Guo-Bin Wu, 2020, Cancer medicine.

A nomogram to predict vascular invasion before resection of colorectal cancer

Weizhong Tang, Guo-Bin Wu, Zhengtian Li, 2019, Oncology letters.

Development and verification of a novel immunogenic cell death‐related signature for predicting the prognosis and immune infiltration in triple‐negative breast cancer

Zhengtian Li, Wenkang Yang, Jiachen Li, 2024, Cancer reports.

Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas

Zhengtian Li, Wenkang Yang, Gang Du, 2024, Journal of cancer research and clinical oncology.